Juvenescence Appoints Dr Richard Marshall CBE as CEO
Juvenescence has named Dr Richard Marshall CBE as its new CEO, effective 16 January 2023. Dr Marshall succeeds co-founder Dr Gregory Bailey, who will remain on the company’s board as...
Juvenescence has named Dr Richard Marshall CBE as its new CEO, effective 16 January 2023. Dr Marshall succeeds co-founder Dr Gregory Bailey, who will remain on the company’s board as...
Biotech Leader to Provide Longevity Insights at Annual Conference Ramsey, Isle of Man – November 1, 2022 – Juvenescence Limited (“Juvenescence”), a life sciences company developing therapies and consumer products...
AgeX Therapeutics announces a manufacturing, marketing and distribution agreement with Pluristyx, an advanced therapy tools and services company, to expand access to clinical-grade human pluripotent stem cells for therapeutic applications.
LyGenesis announces four new peer-reviewed publications highlighting its advancing technology for kidney and liver regeneration.
November 17, 2022 | London
Our Chief Financial Officer, David Gill, and our Chief Science Officer, Martin Ducker, highlight the importance of aging as a risk factor of chronic diseases, and how Juvenescence taps into clinical and commercial opportunities.
Dr. Greg Bailey hosted Web Summit's 2022 HealthConf track where industry giants, disruptive startups, investors & innovators gathered to redefine healthcare.
Through healthy habits and anti-aging drugs, we have every possibility of getting another 8-10 healthy years. Watch Greg's interview with Voister at Web Summit in Lisbon.
Dr. Greg Bailey and Jim Mellon at Master Investor's flagship event for private investors, ‘The Master Investor Show’. This conference includes presentations from leading companies and experts within the financial and investment sectors.
Dr. Gregory Bailey, MD and Jim Mellon, co-founders of Juvenescence, brought together the leading experts in ketone metabolism and longevity to discuss new science regarding ketones, new investment opportunities, and an exciting, new Rx development initiative from Juvenescence.
The lifespan revolution is coming – find out how to connect, collaborate and invest. Dr. Greg Bailey and Jim Mellon spoke about investment opportunities and the future of the industry.